Review: taking Risperidone and Keppra together


Summary

Drug interactions are reported among people who take Risperidone and Keppra together. This review analyzes the effectiveness and drug interactions between Risperidone and Keppra. It is created by eHealthMe based on reports of 632 people who take the same drugs from FDA and social media, and is updated regularly.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Risperidone

Risperidone has active ingredients of risperidone. It is often used in schizophrenia. (latest outcomes from Risperidone 23,150 users)

Keppra

Keppra has active ingredients of levetiracetam. It is often used in epilepsy. (latest outcomes from Keppra 36,049 users)

On Sep, 16, 2016

632 people who take Risperidone, Keppra are studied.


Number of reports submitted per year:

Risperidone and Keppra drug interactions.

Drug effectiveness over time:

Risperidone:
  • < 1 month: 0.0% - (0 of 2 people)
  • 1 - 6 months: 50.0% - (1 of 2 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 0.0% - (0 of 0 people)
  • 2 - 5 years: 33.0% - (1 of 3 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)
Keppra:
  • < 1 month: 0.0% - (0 of 1 people)
  • 1 - 6 months: 0.0% - (0 of 2 people)
  • 6 - 12 months: 50.0% - (1 of 2 people)
  • 1 - 2 years: 100.0% - (1 of 1 people)
  • 2 - 5 years: 0.0% - (0 of 1 people)
  • 5 - 10 years: 100.0% - (1 of 1 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Risperidone:
  • female: 20.0% - (1 of 5 people)
  • male: 50.0% - (1 of 2 people)
Keppra:
  • female: 33.0% - (2 of 6 people)
  • male: 50.0% - (1 of 2 people)

Drug effectiveness by age:

Risperidone:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 100.0% - (1 of 1 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 2 people)
  • 30-39: 0.0% - (0 of 0 people)
  • 40-49: 0.0% - (0 of 2 people)
  • 50-59: 0.0% - (0 of 1 people)
  • 60+: 100.0% - (1 of 1 people)
Keppra:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 100.0% - (1 of 1 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 50.0% - (1 of 2 people)
  • 30-39: 0.0% - (0 of 0 people)
  • 40-49: 0.0% - (0 of 2 people)
  • 50-59: 0.0% - (0 of 1 people)
  • 60+: 50.0% - (1 of 2 people)

Most common drug interactions over time *:

< 1 month:
  • epilepsy
  • anger
  • anticonvulsant drug level decreased
  • psychiatric symptom
  • convulsion
  • drug ineffective
  • aggression
  • alanine aminotransferase increased
  • aspartate aminotransferase increased
  • schizophrenia
1 - 6 months:
  • epilepsy
  • pneumonia
  • convulsion
  • abnormal behaviour
  • aggression
  • depression
  • somnolence
  • tremor
  • anger
  • anticonvulsant drug level decreased
6 - 12 months:
  • convulsion
  • urinary tract infection
  • muscular weakness
  • pneumonia
  • anxiety disorder
  • bedwetting
  • generalised anxiety disorder
  • insomnia
  • irritable bowel syndrome
  • multiple sclerosis relapse
1 - 2 years:
  • cerebrovascular accident
  • convulsion
  • deep vein thrombosis
  • delirium tremens
  • diabetes mellitus
  • drug dependence
  • dysarthria
  • dysphagia
  • hallucination, auditory
  • headache
2 - 5 years:
  • diabetes mellitus
  • diabetic neuropathy
  • headache
  • abdominal pain
  • asthenia
  • cerebrovascular accident
  • chest pain
  • decreased appetite
  • fall
  • hyponatraemia
5 - 10 years:
  • convulsion
  • depression
  • dyskinesia
  • movement disorder
  • pain
  • tardive dyskinesia
  • tremor
  • urinary retention
  • weight decreased
10+ years:
  • adverse drug reaction
  • arthralgia
  • back pain
  • blindness
  • bone disorder
  • cardiac disorder
  • diabetes mellitus
  • disability
  • erectile dysfunction
  • gynaecomastia
not specified:
  • convulsion
  • anxiety
  • depression
  • agitation
  • confusional state
  • aggression
  • drug ineffective
  • somnolence
  • epilepsy
  • tremor

Most common drug interactions by gender *:

female:
  • convulsion
  • epilepsy
  • anxiety
  • agitation
  • nausea
  • tremor
  • drug ineffective
  • headache
  • urinary tract infection
  • asthenia
male:
  • convulsion
  • somnolence
  • aggression
  • epilepsy
  • confusional state
  • depression
  • drug ineffective
  • weight increased
  • abnormal behaviour
  • suicide attempt

Most common drug interactions by age *:

2-9:
  • aggression
  • abnormal behaviour
  • agitation
  • respiratory distress
  • convulsion
  • drug ineffective
  • dyskinesia
  • psychomotor hyperactivity
  • rash
  • affect lability
10-19:
  • aggression
  • convulsion
  • anxiety
  • abnormal behaviour
  • electrocardiogram qt prolonged
  • lethargy
  • tic
  • weight increased
  • blood prolactin increased
  • depression
20-29:
  • agitation
  • schizophrenia
  • dyskinesia
  • suicide attempt
  • hallucination, auditory
  • intentional self-injury
  • oculogyric crisis
  • overdose
  • parkinsonism
  • tension
30-39:
  • convulsion
  • thrombocytopenia
  • agitation
  • dizziness
  • grand mal convulsion
  • drug level increased
  • dystonia
  • hypertension
  • hyponatraemia
  • metabolic disorder
40-49:
  • convulsion
  • tremor
  • urinary tract infection
  • diabetes mellitus
  • insomnia
  • psychotic disorder
  • asthenia
  • depression
  • dyspnoea
  • extrapyramidal disorder
50-59:
  • epilepsy
  • somnolence
  • hyponatraemia
  • anger
  • anticonvulsant drug level decreased
  • psychiatric symptom
  • depressed level of consciousness
  • headache
  • asthenia
  • coma
60+:
  • confusional state
  • depression
  • lethargy
  • alanine aminotransferase increased
  • convulsion
  • delirium
  • syncope
  • epilepsy
  • hypertension
  • pyrexia

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Risperidone and Keppra?

Can you answer these questions?

More questions for: Risperidone, Keppra

You may be interested in these reviews

More reviews for: Risperidone, Keppra

On eHealthMe, Risperidone (risperidone) is often used to treat schizophrenia. Keppra (levetiracetam) is often used to treat epilepsy. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.